Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Global Value Dossier

- PMLiVE

Pfizer and Innovent Biologics agree on deal worth up to $10.5bn

The companies plan to research and develop 12 new cancer treatments

- PMLiVE

EMA celebrates diversity and inclusion in science and healthcare

The EU body underlines its commitment to diverse perspectives in medicines regulation

Roadmap visual

Where it all began – why we developed The Experience Gap

Learn how The Experience Gap was developed to help sponsors, CROs and site teams improve clinical trial participation by identifying friction points, enhancing patient experience, and driving better recruitment and...

Cuttsy + Cuttsy

- PMLiVE

What do HCPs want from pharma medical information sites in 2026?

At Graphite, we regularly carry out first-hand research with healthcare professionals (HCPs) to understand how they interact with digital experiences in practice. When you combine those conversations with wider sector...

Graphite Digital

- PMLiVE

Bridging the value gap: The systems, teams and mindsets that matter

In pharma, the challenge is no longer understanding what HCPs want from digital. It’s delivering it consistently. In this webinar, we explored what needs to change inside organisations to make...

Graphite Digital

- PMLiVE

GSK announces bepirovirsen’s ‘functional cure’ data to treat chronic hepatitis B

Over 240 million people worldwide live with chronic hepatitis B

- PMLiVE

The blind spot undermining pharma product launches – and how to eliminate it

Something critical is missing: a clear view of what’s actually happening on the ground

- PMLiVE

Delphia Therapeutics appoints David Kerstein as Chief Medical Officer

Kerstein was most recently CMO of IDRx, a company acquired by GSK in 2025

- PMLiVE

NICE recommends Genmab’s Tivdak for recurrent or metastatic cervical cancer

It is estimated that 3,300 women are diagnosed with cervical cancer in the UK each year

- PMLiVE

Closing the last mile: translating national market access into real-world patient access in the UK

UK market access needs the right conditions nationally, along with subnational investment and delivery locally

- PMLiVE

The Ripple Effect: Why Connection is the Heart of Healthcare Leadership

In the fast-paced environment of clinical medicine, it is easy to focus solely on data and outcomes. However, as Dr. Toyin Nwafor (Gilead Sciences) and Dr. Shirin Mazumder (University of...

Medscape Education

- PMLiVE

Why HCP AI use is now a brand strategy opportunity for pharma

For pharma brands, AI visibility is no longer just a digital question, it is fast becoming a brand strategy imperative

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links